Perfuse Therapeutics

0 followers

Perfuse Therapeutics is a seed-stage company pursuing a novel mechanism to improve retinal perfusion in the context of various retinal diseases starting with glaucoma

Industries

Employees

1-10

Links


Org chart

Andrew Melie
Analytical Scientist
Christopher Romeo
Principal Scientist, Device And Formulation
Heather Schmitt
Clinical Development Scientist
Maria Zaretskaia, M.D.
Principal Scientist, Pharmacology & Toxicology
Karen Brennan
Vice President, Pharmaceutical Development
Phillip Lai
Chief Medical Officer
Angela Glendenning
Vice President Of Product Development

Teams

This company has no teams yet